177 related articles for article (PubMed ID: 27998038)
1. Whole-exome sequencing predicted cancer epitope trees of 23 early cervical cancers in Chinese women.
Li X; Huang H; Guan Y; Gong Y; He CY; Yi X; Qi M; Chen ZY
Cancer Med; 2017 Jan; 6(1):207-219. PubMed ID: 27998038
[TBL] [Abstract][Full Text] [Related]
2. Landscape of genomic alterations in cervical carcinomas.
Ojesina AI; Lichtenstein L; Freeman SS; Pedamallu CS; Imaz-Rosshandler I; Pugh TJ; Cherniack AD; Ambrogio L; Cibulskis K; Bertelsen B; Romero-Cordoba S; Treviño V; Vazquez-Santillan K; Guadarrama AS; Wright AA; Rosenberg MW; Duke F; Kaplan B; Wang R; Nickerson E; Walline HM; Lawrence MS; Stewart C; Carter SL; McKenna A; Rodriguez-Sanchez IP; Espinosa-Castilla M; Woie K; Bjorge L; Wik E; Halle MK; Hoivik EA; Krakstad C; Gabiño NB; Gómez-Macías GS; Valdez-Chapa LD; Garza-Rodríguez ML; Maytorena G; Vazquez J; Rodea C; Cravioto A; Cortes ML; Greulich H; Crum CP; Neuberg DS; Hidalgo-Miranda A; Escareno CR; Akslen LA; Carey TE; Vintermyr OK; Gabriel SB; Barrera-Saldaña HA; Melendez-Zajgla J; Getz G; Salvesen HB; Meyerson M
Nature; 2014 Feb; 506(7488):371-5. PubMed ID: 24390348
[TBL] [Abstract][Full Text] [Related]
3. Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses.
Kuhn E; Wu RC; Guan B; Wu G; Zhang J; Wang Y; Song L; Yuan X; Wei L; Roden RB; Kuo KT; Nakayama K; Clarke B; Shaw P; Olvera N; Kurman RJ; Levine DA; Wang TL; Shih IeM
J Natl Cancer Inst; 2012 Oct; 104(19):1503-13. PubMed ID: 22923510
[TBL] [Abstract][Full Text] [Related]
4.
Liu F; Zou Y; Wang F; Yang B; Zhang Z; Luo Y; Liang M; Zhou J; Huang O
Genet Test Mol Biomarkers; 2019 Jun; 23(6):409-417. PubMed ID: 31161818
[No Abstract] [Full Text] [Related]
5. Whole exome sequence analysis of serous borderline tumors of the ovary.
Boyd J; Luo B; Peri S; Wirchansky B; Hughes L; Forsythe C; Wu H
Gynecol Oncol; 2013 Sep; 130(3):560-4. PubMed ID: 23774303
[TBL] [Abstract][Full Text] [Related]
6. Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome.
Lu X; Jiang L; Zhang L; Zhu Y; Hu W; Wang J; Ruan X; Xu Z; Meng X; Gao J; Su X; Yan F
Neoplasia; 2019 Jun; 21(6):591-601. PubMed ID: 31055200
[TBL] [Abstract][Full Text] [Related]
7. Multi-region sequencing depicts intratumor heterogeneity and clonal evolution in cervical cancer.
Wang C; Bai R; Liu Y; Wang K; Wang Y; Yang J; Cai H; Yang P
Med Oncol; 2023 Jan; 40(2):78. PubMed ID: 36635412
[TBL] [Abstract][Full Text] [Related]
8. TP53, PIK3CA, FBXW7 and KRAS Mutations in Esophageal Cancer Identified by Targeted Sequencing.
Zheng H; Wang Y; Tang C; Jones L; Ye H; Zhang G; Cao W; Li J; Liu L; Liu Z; Zhang C; Lou F; Liu Z; Li Y; Shi Z; Zhang J; Zhang D; Sun H; Dong H; Dong Z; Guo B; Yan HE; Lu Q; Huang X; Chen SY
Cancer Genomics Proteomics; 2016; 13(3):231-8. PubMed ID: 27107065
[TBL] [Abstract][Full Text] [Related]
9. Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes.
Le Gallo M; O'Hara AJ; Rudd ML; Urick ME; Hansen NF; O'Neil NJ; Price JC; Zhang S; England BM; Godwin AK; Sgroi DC; ; Hieter P; Mullikin JC; Merino MJ; Bell DW
Nat Genet; 2012 Dec; 44(12):1310-5. PubMed ID: 23104009
[TBL] [Abstract][Full Text] [Related]
10. Epithelial ovarian cancer: rationale for changing the one-fits-all standard treatment regimen to subtype-specific treatment.
Despierre E; Yesilyurt BT; Lambrechts S; Johnson N; Verheijen R; van der Burg M; Casado A; Rustin G; Berns E; Leunen K; Amant F; Moerman P; Lambrechts D; Vergote I;
Int J Gynecol Cancer; 2014 Mar; 24(3):468-77. PubMed ID: 24557434
[TBL] [Abstract][Full Text] [Related]
11. Identification of molecular targets in vulvar cancers.
Palisoul ML; Mullen MM; Feldman R; Thaker PH
Gynecol Oncol; 2017 Aug; 146(2):305-313. PubMed ID: 28536037
[TBL] [Abstract][Full Text] [Related]
12. T cell neoepitope discovery in colorectal cancer by high throughput profiling of somatic mutations in expressed genes.
Mennonna D; Maccalli C; Romano MC; Garavaglia C; Capocefalo F; Bordoni R; Severgnini M; De Bellis G; Sidney J; Sette A; Gori A; Longhi R; Braga M; Ghirardelli L; Baldari L; Orsenigo E; Albarello L; Zino E; Fleischhauer K; Mazzola G; Ferrero N; Amoroso A; Casorati G; Parmiani G; Dellabona P
Gut; 2017 Mar; 66(3):454-463. PubMed ID: 26681737
[TBL] [Abstract][Full Text] [Related]
13. Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy.
Zammataro L; Lopez S; Bellone S; Pettinella F; Bonazzoli E; Perrone E; Zhao S; Menderes G; Altwerger G; Han C; Zeybek B; Bianchi A; Manzano A; Manara P; Cocco E; Buza N; Hui P; Wong S; Ravaggi A; Bignotti E; Romani C; Todeschini P; Zanotti L; Odicino F; Pecorelli S; Donzelli C; Ardighieri L; Angioli R; Raspagliesi F; Scambia G; Choi J; Dong W; Bilguvar K; Alexandrov LB; Silasi DA; Huang GS; Ratner E; Azodi M; Schwartz PE; Pirazzoli V; Stiegler AL; Boggon TJ; Lifton RP; Schlessinger J; Santin AD
Proc Natl Acad Sci U S A; 2019 Nov; 116(45):22730-22736. PubMed ID: 31624127
[TBL] [Abstract][Full Text] [Related]
14. The landscape of somatic mutations in Indonesian cervical cancer is predominated by the PI3K pathway.
Spaans VM; Nyoman Bayu Mahendra I; Purwoto G; Trietsch MD; Osse M; Ter Haar N; Peters AAW; Fleuren GJ; Jordanova ES
Gynecol Oncol; 2018 Jan; 148(1):189-196. PubMed ID: 29113722
[TBL] [Abstract][Full Text] [Related]
15. Increased incidence of FBXW7 and POLE proofreading domain mutations in young adult colorectal cancers.
Kothari N; Teer JK; Abbott AM; Srikumar T; Zhang Y; Yoder SJ; Brohl AS; Kim RD; Reed DR; Shibata D
Cancer; 2016 Sep; 122(18):2828-35. PubMed ID: 27244218
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of oral squamous cell carcinoma using targeted next-generation sequencing.
Er TK; Wang YY; Chen CC; Herreros-Villanueva M; Liu TC; Yuan SS
Oral Dis; 2015 Oct; 21(7):872-8. PubMed ID: 26173098
[TBL] [Abstract][Full Text] [Related]
17. Loss of FBXW7 is related to the susceptibility and poor prognosis of cervical squamous carcinoma.
Xu Y; Yu J; Liu T; Meng F; Kong D; Lou G
Biomarkers; 2016; 21(4):379-85. PubMed ID: 26954701
[TBL] [Abstract][Full Text] [Related]
18. Mutant MHC class II epitopes drive therapeutic immune responses to cancer.
Kreiter S; Vormehr M; van de Roemer N; Diken M; Löwer M; Diekmann J; Boegel S; Schrörs B; Vascotto F; Castle JC; Tadmor AD; Schoenberger SP; Huber C; Türeci Ö; Sahin U
Nature; 2015 Apr; 520(7549):692-6. PubMed ID: 25901682
[TBL] [Abstract][Full Text] [Related]
19. miR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7.
Zhou C; Shen L; Mao L; Wang B; Li Y; Yu H
Biochem Biophys Res Commun; 2015 Feb; 458(1):63-9. PubMed ID: 25623537
[TBL] [Abstract][Full Text] [Related]
20. T-cell response to human papillomavirus type 52 L1, E6, and E7 peptides in women with transient infection, cervical intraepithelial neoplasia, and invasive cancer.
Chan PK; Liu SJ; Cheung JL; Cheung TH; Yeo W; Chong P; Man S
J Med Virol; 2011 Jun; 83(6):1023-30. PubMed ID: 21503915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
